Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Saigo

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|January 4, 2001
Paclitaxel-based chemotherapy in carcinoma of the fallopian tubeM L Gemignani, M L Hensley, R Cohen, et al.
Obstetrics and Gynecology|October 1, 1992
Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 casesR R Barakat, S C Rubin, G Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancerS H Olson, C L Finstad, S Harlap, et al.
American Journal of Obstetrics and Gynecology|February 1, 1995
Genital ulcer disease in women infected with human immunodeficiency virusK D LaGuardia, M H White, P E Saigo, et al.
Gynecologic Oncology|December 1, 1995
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potentialR R Barakat, I Benjamin, J L Lewis, et al.
The American Journal of Pathology|February 1, 1993
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding proteinP Garin-Chesa, I Campbell, P E Saigo, et al.
Annals of Surgery|November 1, 1981
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor sizeP P Rosen, P E Saigo, D W Braun, et al.
Obstetrics and Gynecology|June 1, 1988
Treatment of uterine leiomyosarcomaA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|June 1, 1988
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinomaS C Rubin, E D Dulaney, M Markman, et al.
Cancer|April 15, 1986
Prognostic factors in adenocarcinoma of the uterine cervixP E Saigo, J M Cain, W S Kim, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|January 4, 2001
Paclitaxel-based chemotherapy in carcinoma of the fallopian tubeM L Gemignani, M L Hensley, R Cohen, et al.
Obstetrics and Gynecology|October 1, 1992
Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 casesR R Barakat, S C Rubin, G Wong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancerS H Olson, C L Finstad, S Harlap, et al.
American Journal of Obstetrics and Gynecology|February 1, 1995
Genital ulcer disease in women infected with human immunodeficiency virusK D LaGuardia, M H White, P E Saigo, et al.
Gynecologic Oncology|December 1, 1995
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potentialR R Barakat, I Benjamin, J L Lewis, et al.
The American Journal of Pathology|February 1, 1993
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding proteinP Garin-Chesa, I Campbell, P E Saigo, et al.
Annals of Surgery|November 1, 1981
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor sizeP P Rosen, P E Saigo, D W Braun, et al.
Obstetrics and Gynecology|June 1, 1988
Treatment of uterine leiomyosarcomaA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|June 1, 1988
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinomaS C Rubin, E D Dulaney, M Markman, et al.
Cancer|April 15, 1986
Prognostic factors in adenocarcinoma of the uterine cervixP E Saigo, J M Cain, W S Kim, et al.
Pageof 6